Clinical trial Recruiting at 22 sites Observational Ages 18 and up

Evaluating a procedure for treating atrial functional mitral regurgitation

Official title: Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation

Run by University Hospital of Cologne · NCT06911099 · Data updated 2026-11-12

This study looks at how well a new heart procedure works for people with atrial functional mitral regurgitation to see if it helps improve their health.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorUniversity Hospital of Cologne
Academic / other
Locations22 sites (The Bronx, New York and 21 other locations)
StatusRecruiting
StartedJanuary 1, 2010
Main results expectedDecember 31, 2030
Study endsDecember 31, 2035
Registry record updatedApril 6, 2025
Trial IDNCT06911099 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with functional mitral regurgitation and a left ventricular ejection fraction of 50% or greater.

Probably not a fit

Patients under 18 years old or those with known regional wall movement disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the outcomes of patients with atrial functional mitral regurgitation who have undergone transcatheter edge-to-edge repair in a clinical setting. It is a multicenter, international, retrospective registry that collects data on patient outcomes to assess the effectiveness of this treatment approach. The study aims to provide insights into the routine clinical management of this condition and its implications for patient care.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies for patients with atrial functional mitral regurgitation.

How similar studies have gone: Other studies have explored similar interventions, but the specific outcomes of this approach in the context of atrial functional mitral regurgitation are still being evaluated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* functional mitral regurgitation
* left ventricular ejection fraction ≥50%

Exclusion Criteria:

* age under 18 years
* known regional wall movement disorders

Where it's running

  • Montefiore Medical Center
    The Bronx, New York, United States
    Recruiting
  • St. Michael's Hospital
    Toronto, Canada
    Recruiting
  • Bordeaux University Hospital
    Bordeaux, France
    Recruiting
  • University Hospital Center of Nantes
    Nantes, France
    Recruiting
  • LMU Klinikum
    Munich, Bavaria, Germany
    Recruiting
  • University Hospital Cologne
    Cologne, North Rhine-Westphalia, Germany
    Recruiting
Show 16 more locations
  • HDZ Bad Oeynhausen
    Bad Oeynhausen, Germany
    Recruiting
  • Heart Center Bonn
    Bonn, Germany
    Recruiting
  • University Hospital of Düsseldorf
    Düsseldorf, Germany
    Recruiting
  • University Heart and Vascular Center Hamburg
    Hamburg, Germany
    Recruiting
  • University Hospital Schleswig-Holstein
    Kiel, Germany
    Recruiting
  • Heart Center Leipzig at University of Leipzig
    Leipzig, Germany
    Recruiting
  • Heart Center of the University Medical Center Mainz
    Mainz, Germany
    Recruiting
  • University Heart Center Ulm
    Ulm, Germany
    Recruiting
  • University of Brescia
    Brescia, Italy
    Recruiting
  • San Raffaele University Hospital
    Milan, Italy
    Recruiting
  • University of Pisa
    Pisa, Italy
    Recruiting
  • Hospital Clinic of Barcelona
    Barcelona, Spain
    Recruiting
  • Reina Sofia University Hospital
    Córdoba, Spain
    Recruiting
  • University Hospital of León
    León, Spain
    Recruiting
  • Asturias Central University Hospital
    Oviedo, Spain
    Recruiting
  • University Hospital Alvaro Cunqueiro
    Vigo, Spain
    Recruiting

Study contacts

  • Principal investigator: Christos Iliadis, MD — Heart Center, Department III of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany
  • Study coordinator: Philipp von Stein, MD
  • Email: philipp.von-stein@uk-koeln.de
  • Phone: 646-321-8145

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.